Sökning: WFRF:(van Gils Carla H.) > Coffee and tea cons...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05924naa a22010093a 4500 | |
001 | 19660107 | |
003 | SE-LIBR | |
005 | 20160906170230.0 | |
007 | cr|||||||||||| | |
008 | 160906s2015 sw |||| o |||| ||eng c | |
024 | 7 | a http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1022452 uri |
024 | 7 | a urn:nbn:se:umu:diva-1022452 urn |
024 | 7 | a 10.1186/s13058-015-0521-32 doi |
040 | a S | |
041 | 0 | a eng |
042 | 9 EPLK | |
100 | 1 | a Bhoo-Pathy, Nirmala4 aut |
245 | 1 0 | a Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort studyh [Elektronisk resurs] |
260 | c 2015 | |
500 | a Published | |
506 | 0 | a gratis |
520 | a Introduction: Specific coffee subtypes and tea may impact risk of pre- and post-menopausal breast cancer differently. We investigated the association between coffee (total, caffeinated, decaffeinated) and tea intake and risk of breast cancer. Methods: A total of 335,060 women participating in the European Prospective Investigation into Nutrition and Cancer (EPIC) Study, completed a dietary questionnaire from 1992 to 2000, and were followed-up until 2010 for incidence of breast cancer. Hazard ratios (HR) of breast cancer by country-specific, as well as cohort-wide categories of beverage intake were estimated. Results: During an average follow-up of 11 years, 1064 premenopausal, and 9134 postmenopausal breast cancers were diagnosed. Caffeinated coffee intake was associated with lower risk of postmenopausal breast cancer: adjusted HR = 0.90, 95% confidence interval (CI): 0.82 to 0.98, for high versus low consumption; P-trend = 0.029. While there was no significant effect modification by hormone receptor status (P = 0.711), linear trend for lower risk of breast cancer with increasing caffeinated coffee intake was clearest for estrogen and progesterone receptor negative (ER-PR-), postmenopausal breast cancer (P = 0.008). For every 100 ml increase in caffeinated coffee intake, the risk of ER-PR- breast cancer was lower by 4% (adjusted HR: 0.96, 95% CI: 0.93 to 1.00). Non-consumers of decaffeinated coffee had lower risk of postmenopausal breast cancer (adjusted HR = 0.89; 95% CI: 0.80 to 0.99) compared to low consumers, without evidence of dose-response relationship (P-trend = 0.128). Exclusive decaffeinated coffee consumption was not related to postmenopausal breast cancer risk, compared to any decaffeinated-low caffeinated intake (adjusted HR = 0.97; 95% CI: 0.82 to 1.14), or to no intake of any coffee (HR: 0.96; 95%: 0.82 to 1.14). Caffeinated and decaffeinated coffee were not associated with premenopausal breast cancer. Tea intake was neither associated with pre- nor post-menopausal breast cancer. Conclusions: Higher caffeinated coffee intake may be associated with lower risk of postmenopausal breast cancer. Decaffeinated coffee intake does not seem to be associated with breast cancer. | |
650 | 7 | a Medical and Health Sciences2 hsv |
650 | 7 | a Clinical Medicine2 hsv |
650 | 7 | a Cancer and Oncology2 hsv |
650 | 7 | a Medicin och hälsovetenskap2 hsv |
650 | 7 | a Klinisk medicin2 hsv |
650 | 7 | a Cancer och onkologi2 hsv |
700 | 1 | a Peeters, Petra H. M.4 aut |
700 | 1 | a Uiterwaal, Cuno S. P. M.4 aut |
700 | 1 | a Bueno-de-Mesquita, H. Bas4 aut |
700 | 1 | a Bulgiba, Awang M.4 aut |
700 | 1 | a Bech, Bodil Hammer4 aut |
700 | 1 | a Overvad, Kim4 aut |
700 | 1 | a Tjønneland, Anne4 aut |
700 | 1 | a Olsen, Anja4 aut |
700 | 1 | a Clavel-Chapelon, Francoise4 aut |
700 | 1 | a Fagherazzi, Guy4 aut |
700 | 1 | a Perquier, Florence4 aut |
700 | 1 | a Teucher, Birgit4 aut |
700 | 1 | a Kaaks, Rudolf4 aut |
700 | 1 | a Schuetze, Madlen4 aut |
700 | 1 | a Boeing, Heiner4 aut |
700 | 1 | a Lagiou, Pagona4 aut |
700 | 1 | a Orfanos, Philippos4 aut |
700 | 1 | a Trichopoulou, Antonia4 aut |
700 | 1 | a Agnoli, Claudia4 aut |
700 | 1 | a Mattiello, Amalia4 aut |
700 | 1 | a Palli, Domenico4 aut |
700 | 1 | a Tumino, Rosario4 aut |
700 | 1 | a Sacerdote, Carlotta4 aut |
700 | 1 | a van Duijnhoven, Franzel J. B.4 aut |
700 | 1 | a Braaten, Tonje4 aut |
700 | 1 | a Lund, Eiliv4 aut |
700 | 1 | a Skeie, Guri4 aut |
700 | 1 | a Redondo, Maria-Luisa4 aut |
700 | 1 | a Buckland, Genevieve4 aut |
700 | 1 | a Sanchez Perez, Maria Jose4 aut |
700 | 1 | a Chirlaque, Maria-Dolores4 aut |
700 | 1 | a Ardanaz, Eva4 aut |
700 | 1 | a Amiano, Pilar4 aut |
700 | 1 | a Wirfalt, Elisabet4 aut |
700 | 1 | a Wallstrom, Peter4 aut |
700 | 1 | a Johansson, Ingegerd4 aut |
700 | 1 | a Nilsson, Lena Maria4 aut |
700 | 1 | a Khaw, Kay-Tee4 aut |
700 | 1 | a Wareham, Nick4 aut |
700 | 1 | a Allen, Naomi E.4 aut |
700 | 1 | a Key, Timothy J.4 aut |
700 | 1 | a Rinaldi, Sabina4 aut |
700 | 1 | a Romieu, Isabelle4 aut |
700 | 1 | a Gallo, Valentina4 aut |
700 | 1 | a Riboli, Elio4 aut |
700 | 1 | a van Gils, Carla H.4 aut |
710 | 1 | a Umeå universitetb Medicinska fakulteten4 pbl0 268483 |
710 | 1 | a Umeå universitetb Medicinska fakulteten4 pbl0 268483 |
772 | 1 8 | i channel recordw 18813935 |
773 | 0 | i Värdpublikationt Breast Cancer Researchg 17x 1465-542X |
856 | 4 0 | u http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-102245 |
856 | 4 0 | u http://dx.doi.org/10.1186/s13058-015-0521-3 |
856 | 4 0 | u http://umu.diva-portal.org/smash/get/diva2:808310/FULLTEXT01 |
910 | 2 s | 6 710,710a Umeå universitet.b Medicinsk-odontologiska fakultetenu Umeå universitet.b Medicinska fakulteten |
910 | 2 s | 6 710,710a Medicinska fakulteten vid Umeå universitetu Umeå universitet.b Medicinska fakulteten |
841 | 5 APISa x ab 160906||0000|||||001||||||000000e 1 | |
024 | 7 | 5 APISa urn:nbn:se:umu:diva-1022452 urn |
852 | 5 APISb APIS | |
856 | 4 0 | 5 APISu http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-102245 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy